Top Midday Stories: Cigna Won't Pursue Combination With Humana; AbbVie Phase 2 Schizophrenia Drug Trials Fail to Meet Primary Endpoints

MT Newswires Live
2024/11/12

All three major US stock indexes were up in late-morning trading Monday, as the post-election rally continues.

In company news, Cigna Group (CI) said Monday it is not pursuing a combination with Humana (HUM), and it expects to communicate that to investors and analysts in meetings over the next several weeks. Shares of Cigna were up 7% around midday, while those of Humana were down 4.4%.

AbbVie (ABBV) said Monday that two phase 2 trials assessing emraclidine in adult patients with schizophrenia and acute exacerbation of psychotic symptoms didn't meet their primary goal. The primary endpoint was an improvement in the change from baseline in the Positive and Negative Syndrome Scale score compared with the placebo group at week six, the company said. Shares of AbbVie were down 11.3%.

MicroStrategy (MSTR) said Monday it increased its bitcoin portfolio to 279,420 as of Nov. 10. The company purchased around 27,200 bitcoins for nearly $2.03 billion in cash during the period from Oct. 31 to Nov. 10 at an average price of about $74,463 per bitcoin, inclusive of fees and expenses. Shares of MicroStrategy were up 19.0%.

Dell Technologies' (DELL) artificial intelligence infrastructure momentum is building "even faster" as more than $20 billion of AI server revenue is anticipated for the company in fiscal 2026, Morgan Stanley said Monday in a note. Morgan Stanley expects the company to ship 48,000 8-GPU AI server equivalents in fiscal 2026, representing 23% growth year over year, the note said. Additionally, Morgan Stanley said that Super Micro Computer's (SMCI) recent challenges represent a "key opportunity" for Dell to gain "incremental share" in fiscal 2026 and unlock an "AI server bull case." Shares of Dell were up 0.9%, while those of Super Micro Computer were down 8.5%.

Price: 342.06, Change: +22.29, Percent Change: +6.97

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10